These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21688630)

  • 1. [Treatment and prevention of NSAIDs-induced gastrointestinal injury--the role of gastroenterologist].
    Yamamoto T; Kuyama Y
    Nihon Rinsho; 2011 Jun; 69(6):1072-4. PubMed ID: 21688630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose aspirin (LDA)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced gastrointestinal injury in Japan].
    Sugano K
    Nihon Rinsho; 2011 Jun; 69(6):977-81. PubMed ID: 21688615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations].
    Hiraishi H; Shimada T
    Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of preventive and therapeutic drugs for NSAIDs ulcers in the gastrointestinal tract].
    Naito Y; Takagi T; Yoshikawa T
    Nihon Rinsho; 2011 Jun; 69(6):1007-15. PubMed ID: 21688620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of NSAIDs and low-dose-aspirin-induced ulcer in patients with cerebral infarction].
    Kimura Y; Uchiyama S
    Nihon Rinsho; 2011 Jun; 69(6):1067-71. PubMed ID: 21688629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of nonsteroidal anti-inflammatory drugs induced ulcers].
    Kobayakawa M; Uemura N
    Nihon Rinsho; 2007 Oct; 65(10):1857-61. PubMed ID: 17926536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate prevention of NSAID-induced gastrointestinal events.
    Herings RM; Goettsch WG
    Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guideline of prevention and treatment for NSAIDs induced ulcer].
    Yoshino J; Inui K; Wakabayashi T; Kobayashi T
    Nihon Rinsho; 2011 Jun; 69(6):1024-31. PubMed ID: 21688622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton pump inhibitor H2 receptor antagonist].
    Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
    Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects].
    Hiraishi H; Akima T; Sugaya T; Nakano M; Nomura M
    Nihon Rinsho; 2011 Jun; 69(6):988-94. PubMed ID: 21688617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
    Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
    Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.